Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Next revisionBoth sides next revision
home:pathogenesis:successive_infection [09.09.2012] – [Evidence from clinical and laboratory-based studies] paulalberthome:pathogenesis:successive_infection [11.25.2016] – [Health and disease is a continuum] sallieq
Line 33: Line 33:
 ===== Successive infection: early infections predispose a person to later chronic disease ==== ===== Successive infection: early infections predispose a person to later chronic disease ====
  
-There is broad support for the conclusion that early infections, especially acute infections, predispose a person to later onset of chronic diseases, diseases which are likely caused by chronic microbial infections. The role beta-lactam antibiotics, which are often prescribed for acute infections, play in fostering the growth of L-form bacteria is discussed elsewhere.+There is broad support for the conclusion that early infections, especially acute infections, predispose a person to later onset of chronic diseases, diseases which are likely caused by chronic microbial infections. The role of beta-lactam antibiotics, which are often prescribed for acute infections, play in fostering the growth of L-form bacteria is discussed elsewhere.
 ==== Hematogenous seeding due to dental infections ==== ==== Hematogenous seeding due to dental infections ====
  
Line 130: Line 130:
  
  
-Clearly, the microbiota can be affected in any number of ways that are not picked up by the relatively crude tests that we use to measure "health." Further, patients carry pathogenic elements of their microbiota but without the symptoms to show for it – at least initially.+Clearly, the microbiota can be affected in any number of ways that are not picked up by the relatively crude tests that we use to measure "health." Further, patients will carry pathogenic elements of their microbiota without symptoms to show for it – at least initially.
  
 The variability of patients' responses – both between control and experimental groups, and among an experimental group (some subjects get a side effect, some don't) – may ultimately be a testament to the unique nature of each person's microbiota. The variability of patients' responses – both between control and experimental groups, and among an experimental group (some subjects get a side effect, some don't) – may ultimately be a testament to the unique nature of each person's microbiota.
home/pathogenesis/successive_infection.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.